KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Steris (STE) Capital Expenditures (2018 - 2025)

Steris has reported Capital Expenditures over the past 8 years, most recently at $98.7 million for Q4 2025.

  • Quarterly results put Capital Expenditures at $98.7 million for Q4 2025, up 10.65% from a year ago — trailing twelve months through Dec 2025 was $349.7 million (down 10.5% YoY), and the annual figure for FY2025 was $370.1 million, up 2.71%.
  • Capital Expenditures for Q4 2025 was $98.7 million at Steris, up from $86.5 million in the prior quarter.
  • Over the last five years, Capital Expenditures for STE hit a ceiling of $118.9 million in Q4 2023 and a floor of $56.4 million in Q2 2021.
  • Median Capital Expenditures over the past 5 years was $84.9 million (2023), compared with a mean of $86.7 million.
  • Biggest five-year swings in Capital Expenditures: surged 105.57% in 2022 and later plummeted 42.55% in 2023.
  • Steris' Capital Expenditures stood at $81.1 million in 2021, then rose by 13.19% to $91.8 million in 2022, then grew by 29.53% to $118.9 million in 2023, then dropped by 25.0% to $89.2 million in 2024, then grew by 10.65% to $98.7 million in 2025.
  • The last three reported values for Capital Expenditures were $98.7 million (Q4 2025), $86.5 million (Q3 2025), and $93.6 million (Q2 2025) per Business Quant data.